Evidence map›Paper›PMID 32928304›Full record

ArticleVeterinary research2020

Acute and long-term effects of antibiotics commonly used in laboratory animal medicine on the fecal microbiota.

Scott W Korte, Rebecca A Dorfmeyer, Craig L Franklin, Aaron C Ericsson

Open access · goldAbstract read
In one paragraph

Article in Veterinary research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Isolation, Characterization, and Epizootiology of Clostridioides cuniculi from Immunodeficient Mice with Enteric Disease.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The gut microbiome of laboratory mice: considerations and best practices for translational research.Mammalian genome : official journal of the International Mammalian Genome Society · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Scott W KorteOffice of Animal Resources, University of Missouri, Columbia, MO, USA.
Rebecca A DorfmeyerMetagenomics Center, University of Missouri, Columbia, MO, USA.
Craig L FranklinMetagenomics Center, University of Missouri, Columbia, MO, USA.
Aaron C EricssonMetagenomics Center, University of Missouri, Columbia, MO, USA. ericssona@missouri.edu.ORCID http://orcid.org/0000-0002-3053-7269
University of Missouri · USMissouri College · US

Funding

The Mutant Mouse Resource and Research Center at the University of Missouri - ResourceU42OD010918 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI Bret Daniel Ulery · 2012 to 2026
$25.1M
Impact of gut microbiota and segmented filamentous bacteria on colitis-associated colorectal cancerK01OD019924 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI ERICSSON, AARON · 2016 to 2020
$573k
NIH HHS K01 OD019924NIH HHS U42 OD010918
6 · The paper itself

Abstract

Biomedical research relies on the use of animal models, and the animals used in those models receive medical care, including antibiotics for brief periods of time to treat conditions such as dermatitis, fight wounds, and suspected bacterial pathogens of unknown etiology. As many mouse model phenotypes are sensitive to changes in the gut microbiota, our goal was to examine the effect of antibiotics commonly administered to mice. Therefore, four treatment groups (subcutaneous enrofloxacin for 7 days, oral enrofloxacin for 14 days, oral trimethoprim-sulfamethoxazole for 14 days, and topical triple antibiotic ointment for 14 days) alongside a fifth control group receiving no treatment (n = 12/group) were included in our study. Fecal samples were collected prior to treatment, immediately after two weeks of exposure, and four weeks after cessation of treatment, and subjected to 16S rRNA library sequencing. The entire experimental design was replicated in mice from two different suppliers. As expected, several treatments including enrofloxacin and triple antibiotic ointment substantially decreased the amount of DNA recovered from fecal material, as well as the microbial richness. Notably, many of these effects were long-lasting with diminished gut microbiota (GM) richness four weeks following exposure, in both substrains of mice. Trimethoprim-sulfamethoxazole induced minimal to no discernible changes in the taxonomic composition beyond that seen in control mice. Collectively, these data highlight the need to consider the impact on GM of brief and seemingly routine use of antibiotics in the clinical care of research animals.

Indexed as

Administration, OralAdministration, TopicalAnimalsAnti-Bacterial AgentsBacitracinEnrofloxacinFecesFemaleInjections, SubcutaneousMiceMice, Inbred C57BLMicrobiotaNeomycinOintmentsPolymyxinsTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsBacitracinEnrofloxacinNeomycinOintmentsPolymyxinsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID32928304
PMCPMC7489021
OpenAlexW3086694289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.